BCBA/ABBVD (BCBA/ABBVD)

Buenos Aires Stock Exchange: BCBA/ABBVD · USD

$30.3

+0.00 (0.0%)· Recorded snapshot

Market cap	777T
Revenue (ttm)	95.4T
Net income (ttm)	9.3T
EPS (ttm)	$546
P/E (trailing)	85.6x
P/E (forward)	19.0x
Dividend	$709 (1.52%)
Volume	33

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 95.4T
Net income (ttm): 9.3T
EPS (ttm): $546
P/E (trailing): 85.6x
P/E (forward): 19.0x
Market cap: 777T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 13:30 UTC

Forward P/E19

P25 n/aP50 n/aP75 n/a

Trailing P/E85.6

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC17.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BCBA/ABBVD indicators

Market & fundamental data

Available fields

238

Groups with data

Currency

USD

Showing 238 of 238 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	United States
Country code	AR
Earnings date	2026-10-30
Employees	57,000
Employees change	2,000
Employees growth	3.64%
Enterprise value	$875.9T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2012
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	ARBCOM4603M9
Last earnings date	2026-07-31
Last refreshed	2026-10-29
Market cap	$777T
Next earnings date	2026-10-30
Price	$30.30
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	bcba/ABBVD
Website	https://www.abbvie.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	41.3x
Average P/E ratio (3Y)	81.44x
Average P/E ratio (5Y)	58.76x
Earnings yield	1.17%
EV/Earnings	94.3x
EV/EBIT	24.89x
EV/EBITDA	18.29x
EV/FCF	32.47x
EV/Sales	8.85x
FCF / EV yield	3.08%
FCF yield	3.47%
Forward P/E	19.04x
Lynch fair value	$1.81
Lynch upside	-94.02%
P/(FCF - SBC) ratio	30.43x
P/(OCF - SBC) ratio	28.3x
P/E ratio	85.6x
P/FCF ratio	28.8x
P/OCF ratio	26.89x
P/S ratio	8.15x
Price/EBITDA ratio	17.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	35.56%
EBITDA margin	47.78%
Effective tax rate	27.39%
FCF margin	27.18%
Gross margin	72.79%
Operating margin	35.56%
Pretax margin	13.51%
Profit margin	9.8%
Profit per employee	$163M
Profitable quarters	6
Profitable years	17
Revenue per employee	$1.7B
ROA	10.51%
ROA (5Y)	8.68%
ROCE	24.49%
ROE (5Y)	1,295.17%
ROIC	17.7%
ROIC (5Y)	21.99%
SBC / revenue	1.52%
Tax / revenue	3.7%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	68.54%
EPS growth (Q)	290.39%
EPS growth (QoQ)	422.72%
EPS growth 10Y	0.21%
EPS growth 3Y	-10.05%
EPS growth 5Y	-0.92%
EPS growth quarters	1
EPS growth years	0
FCF growth	-0.16%
FCF growth (Q)	-36.24%
FCF growth (QoQ)	-12.63%
FCF growth 3Y	-9.78%
FCF growth 5Y	-1.43%
Gross profit growth	12.78%
Gross profit growth (Q)	14.64%
Gross profit growth 3Y	5.88%
Gross profit growth 5Y	5.07%
Net income growth	67.69%
Net income growth (Q)	285.18%
Net income growth (QoQ)	424.16%
Net income growth 3Y	-10.12%
Net income growth 5Y	-1.02%
Net income growth quarters	1
Net income growth years	0
OCF growth	1.16%
OCF growth (Q)	-33.32%
OCF growth (QoQ)	-10.26%
OCF growth 10Y	9.1%
OCF growth 3Y	-8.59%
OCF growth 5Y	-0.94%
Operating income growth	21.17%
Operating income growth (Q)	17.54%
Operating income growth 3Y	3.56%
Operating income growth 5Y	3.75%
Revenue growth	10.39%
Revenue growth (Q)	10.16%
Revenue growth (QoQ)	13.25%
Revenue growth 10Y	10.03%
Revenue growth 3Y	4.75%
Revenue growth 5Y	3.69%
Revenue growth quarters	10
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-1.9T
Depreciation and amortization	$12.1T
EBIT	$33.9T
EBITDA	$45.6T
EPS	$545.73
Financing cash flow	$-19.1T
Free cash flow	$27T
Free cash flow minus SBC	$25.5T
Gross profit	$69.4T
Income taxes	$3.5T
Investing cash flow	$-9.6T
Net borrowing	$644.4B
Net cash flow	$151.1B
Net income	$9.3T
Operating cash flow minus SBC	$27.5T
Operating income	$33.9T
Revenue	$95.4T
Stock-based compensation	$1.4T

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.42
Book value per share	$-4,975.87
Debt / EBITDA	2.28
Debt / FCF	3.89
Goodwill	$54.8T
Interest coverage	7.85
Long-term assets	$148.3T
Long-term liabilities	$144.7T
Net cash (debt)	$-95.3T
Net cash / market cap	-12.26%
Net debt / EBITDA	2.09
Net debt / FCF	3.53
Piotroski F-Score	8
Property, plant and equipment	$8.9T
Shareholders' equity	$-8.7T
Tangible book value	$-134.2T
Tangible book value per share	$-75,952.61
Total assets	$200.2T
Total cash	$9.7T
Total debt	$105T
Total liabilities	$208.9T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.47
Current assets	$51.9T
Current liabilities	$64.2T
Current ratio	0.81
Inventory turnover	3.47
Net working capital	$-9.2T
Quick ratio	0.49
Working capital	$-11.8T
Working capital turnover	-10,323.92

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.03%
Dividend growth	23.65%
Dividend growth (3Y)	6.16%
Dividend growth years	1
Dividend payment date	2026-11-16
Dividend payment years	6
Dividend payout frequency	Quarterly
Dividend per share	$709.04
Dividend yield	1.52%
Ex-dividend date	2026-10-15
Last dividend	$0.17
Payout ratio	189.83%
Shareholder yield	1.49%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$25.08
1D price change	0%
1M price change	9.27%
1M total return	9.91%
1W price change	2.02%
1W total return	2.02%
1Y price change	35.21%
1Y return CAGR	38.05%
1Y total return	38.02%
20-day SMA	$29.24
200-day SMA	$24.57
3M price change	12.35%
3M total return	13.01%
3Y price change	124.44%
3Y return CAGR	33.72%
3Y total return	139.17%
50-day SMA	$28.04
50-day SMA vs 200-day SMA	50over200
52-week high	$31.07
52-week high date	2026-10-26
52-week low	$20.13
52-week low date	2026-04-29
5Y price change	169.33%
5Y return CAGR	24.72%
5Y total return	201.66%
6M price change	47.09%
6M total return	48.59%
All-time high	$31.07
All-time high date	2026-10-26
All-time low	$10.75
All-time low date	2021-09-24
Average true range (ATR)	$0.70
Average volume	258.7
Change from 52-week high	-2.48%
Change from 52-week low	50.52%
Change from all-time high	-2.48%
Change from all-time low	181.86%
Change from open	-0.16%
Day's gap	0.17%
Dollar volume	$1,000
High price	$30.57
Low price	$30.30
Monthly RSI	76.87
Open price	$30.35
Position in 52-week range	0%
Previous close	$30.30
Price vs 150-day SMA	20.8%
Price vs 20-day SMA	3.64%
Price vs 200-day SMA	23.31%
Price vs 50-day SMA	8.04%
Relative volume	0.13
RSI	62.02
Sharpe ratio	0.88
Sharpe ratio (3Y)	0.64
Sortino ratio	1.52
Sortino ratio (3Y)	1.07
Volume	33
Weekly RSI	68.84
YTD price change	29.49%
YTD total return	32.18%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.8B
Shares change (QoQ)	-0.23%
Shares change (YoY)	0.03%
Shares held by insiders	0.07%
Shares held by institutions	76.62%
Short ratio	3.2 days

Deeper analysis on BCBA/ABBVD

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BCBA/ABBVD report

Is a complete BCBA/ABBVD research report available?

No complete published report is available for bcba/ABBVD (BCBA/ABBVD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/ABBVD (BCBA/ABBVD)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/ABBVD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/ABBVD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/ABBVD

Frequently asked questions